Want to see NBIX full AI Analyst Report?
Neurocrine (NBIX) Ownership Overview
1.14% Insiders
25.61% Mutual Funds
2.71% Other Institutional Investors
32.41% ETFs
38.13% Public Companies and Individual Investors
The ownership structure of Neurocrine (NBIX) stock is a mix of institutional, retail, and individual investors. Approximately 60.73% of the company’s stock is owned by Institutional Investors, 1.14% is owned by Insiders, and 38.13% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $4601006 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $34663773 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $941218594 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $82807987 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,462,711 | Institution | 12.26% | 1,813,698,332 | |
| 8,798,186 | Institution | 8.66% | 1,280,400,009 | |
| 7,980,917 | Institution | 7.85% | 1,161,462,851 | |
| 5,584,707 | Institution | 5.49% | 812,742,410 | |
| 4,419,163 | Institution | 4.35% | 643,120,791 | |
| 3,209,966 | Institution | 3.16% | 467,146,352 | |
| 1,808,001 | Institution | 1.78% | 263,118,386 | |
| 1,358,475 | Institution | 1.34% | 197,698,867 | |
| 1,127,044 | Institution | 1.11% | 164,018,713 | |
| 1,116,674 | Institution | 1.10% | 162,509,567 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,980,917 | Institution | 7.85% | 1,161,462,851 | |
| 4,419,163 | Institution | 4.35% | 643,120,791 | |
| 1,358,475 | Institution | 1.34% | 197,698,867 | |
| 1,116,674 | Institution | 1.10% | 162,509,567 | |
| 993,422 | Institution | 0.98% | 144,572,704 | |
| 673,925 | Institution | 0.66% | 98,076,305 | |
| 637,614 | Institution | 0.63% | 92,791,965 | |
| 618,394 | Institution | 0.61% | 89,994,879 | |
| 468,475 | Institution | 0.46% | 68,177,167 | |
| 370,409 | Institution | 0.36% | 53,905,622 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,647,455 | Institution | 3.59% | 530,814,126 | |
| 3,234,730 | Institution | 3.18% | 458,814,103 | |
| 3,000,296 | Institution | 2.95% | 285,478,164 | |
| 2,288,159 | Institution | 2.25% | 324,552,473 | |
| 1,272,703 | Institution | 1.25% | 180,520,194 | |
| 1,144,569 | Institution | 1.13% | 162,345,667 | |
| 974,750 | Institution | 0.96% | 142,313,500 | |
| 773,637 | Institution | 0.76% | 112,587,393 | |
| 764,955 | Institution | 0.75% | 111,323,901 | |
| 747,703 | Institution | 0.74% | 108,813,218 |
FAQ
Who Owns Neurocrine (NBIX)?
According to the latest TipRanks data, approximately 2.71% of the company's stock is held by institutional investors, 1.14% is held by insiders, and 38.13% is held by retail investors.
What percentage of Neurocrine (NBIX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.71% of Neurocrine (NBIX) stock is held by institutional investors.
What percentage of Neurocrine (NBIX) stock is held by retail investors?
According to the latest TipRanks data, approximately 38.13% of Neurocrine (NBIX) stock is held by retail investors.
Who owns the most shares of Neurocrine (NBIX)?
iShares owns the most shares of Neurocrine (NBIX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.